Cercle Funding: How Much Did They Raise & Key Investors

How Much Did Cercle Raise?
Funding & Key Investors

Cercle has successfully secured a major strategic investment, marking a pivotal moment in its growth trajectory within the health-tech sector. With a total funding amount reaching $6M, the company is well-positioned to scale its operations. This recent funding amount of $6M serves as a catalyst for the firm to accelerate the deployment of its proprietary software platform, reinforcing its commitment to transforming the landscape of women's healthcare through data-driven insights.

The capital infusion underscores investor confidence in Cercle's ability to bridge the gap between raw healthcare data and actionable clinical intelligence. By leveraging this financing, the company aims to solidify its market presence and expand its reach among healthcare providers seeking to optimize business efficiency and patient outcomes.

What is Cercle?

Cercle

Software

Healthcare Software

Cercle operates at the intersection of advanced data analytics and specialized medical care. Its core offering, the Cercle Biomedical Graph, functions as a sophisticated software platform designed to ingest and transform de-identified healthcare data into real-time, high-quality insights. This technology is specifically engineered for women's healthcare providers, enabling them to streamline administrative workflows and deliver more personalized, evidence-based care. By converting complex datasets into intuitive, actionable intelligence, Cercle addresses critical inefficiencies in the current healthcare infrastructure, positioning itself as an essential partner for modern clinical practices.

How much funding has Cercle raised?

Cercle has raised a total of $6M across 1 funding round:

2024

Angel/Seed

$6M

Angel/Seed (2024): $6M with participation from Outsiders Fund and FemHealth Ventures

Key Investors in Cercle

Outsiders Fund

Outsiders Fund is an early-stage venture capital firm that supports founders with unique perspectives aiming to disrupt outdated industries, focusing on seed and Series A investments in overlooked sectors.

FemHealth Ventures

FemHealth Ventures is a specialized venture capital firm dedicated to investing in women's health, targeting conditions that affect women to drive both innovation and exceptional financial returns.

What's next for Cercle?

With this major enterprise-level funding, Cercle is poised to enter a phase of rapid scaling and product refinement. The strategic roadmap likely involves expanding the capabilities of the Cercle Biomedical Graph to incorporate broader diagnostic datasets and enhancing the platform's interoperability with existing electronic health record systems. As the company matures, the focus will shift toward deepening its market penetration and establishing long-term partnerships with large-scale healthcare networks. By prioritizing the integration of high-fidelity data, Cercle is set to redefine the standard of care in the women's health sector, ensuring that providers have the necessary tools to navigate an increasingly complex medical environment.

See full Cercle company page

See More Financial Insights